Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ Agonists
- 23 May 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (13) , 2061-2064
- https://doi.org/10.1021/jm0155188
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and AtherogenesisMolecular Cell, 2001
- Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce AdiposityJournal of Biological Chemistry, 2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- The isoxazolidine-3,5-dione hypoglycemic agent JTT-501 and other nonthiazolidinedione insulin sensitizersDrugs of the Future, 1999
- Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsNature, 1997
- Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.Journal of Clinical Investigation, 1996
- Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agentsJournal of Medicinal Chemistry, 1992
- Novel thiazolidine-2,4-diones as potent euglycemic agents.Journal of Medicinal Chemistry, 1992
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990